Olga Carroll, Ph.D.

Director, Regulatory Affairs - Oncology, Rare Disease, Neurology & Neurodegenerative Disease at Mallinckrodt Pharma

LINKS

https://www.linkedin.com/in/olga-carroll-ph-d-a9742522

https://www.xing.com/profile/Olga_Carroll

olgacarroll@aol.com
516-343-3023
https://www.facebook.com/pages/OC-Consulting-LLC/128724110537401?ref_type=bookmark

Experience

Director, Regulatory Affairs - Oncology, Neurology & Neurodegenerative Disease

Mallinckrodt Pharmaceuticals

October 2014 – Present (1 year 7 months)

GRA, Clinical, Compliance Strategy, Competitive Intelligence

OC Consulting, LLC

March 2010 – Present (6 years 2 months)Long Island, New York, USA

I provide a variety of GRA, global policy, intelligence and strategy, clinical, medical, CMC, Compliance, QA, PV and PM services to my clients in the US, EU, AP, Eastern Europe, Northern Africa and Latin America.

OC Consulting, LLC logo

Director, Global Regulatory Affairs Oncology, Neurology, Full Time Consultant

NexGenix Pharmaceuticals

August 2009 – March 2010 (8 months)remote and NYC

Deputy Director, Global Regulatory Affairs Strategy - TA -Oncology

Bayer HealthCare

February 2008 – July 2009 (1 year 6 months)Montville, NJ

VP, Regulatory Affairs and Compliance

Syntho-Intermax Pharmaceuticals, Inc.

October 2004 – August 2007 (2 years 11 months)Melville, NY

Director of Regulatory Affairs

Taro Pharmaceuticals, Inc.

May 2004 – October 2004 (6 months)

Courses

OC Consulting, LLC

Pharmaceutical Development with Focus on Japan and Asia Pacific Region to Gain Regulatory Approval in Therapeutic Areas where High Unmet Medical Need Exists (www.pvcertification.com)